Percutaneous Sodium Tetradecyl Sulfate Sclerotherapy for Peripheral Venous Vascular Malformations: A Single-Center Experience

Tan, Kong Teng; Kirby, John M.; Rajan, Dheeraj K.; Hayeems, Eran; Beecroft, R.; Simons, Martin

doi:10.1016/j.jvir.2006.12.735

Cited by 79 publications

(78 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This group also noted that the severity of the symptoms did not usually correlate with the size of the malformation, with location and nature of the malformation being more definitive indicators. 10 Consistent with these findings, our examination of preand postsclerotherapy MR imaging found that, despite a perception of treatment-related improvement in 90.6% of patients and 93.8% of clinicians (results comparable to those published in the literature), MR imaging demonstrated Twenty-two-year old patient with a large diffuse venous malformation of the right cheek and oropharynx, who presented with swelling leading to oral obstruction and obstructive sleep apnea. Both components of the lesion were treated.…”

Section: Discussionsupporting

confidence: 86%

Percutaneous Sclerotherapy for Facial Venous Malformations: Subjective Clinical and Objective MR Imaging Follow-Up Results

Spence¹,

Krings²,

terBrugge³

et al. 2009

AJNR Am J Neuroradiol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 86%

Percutaneous Sclerotherapy for Facial Venous Malformations: Subjective Clinical and Objective MR Imaging Follow-Up Results

Spence¹,

Krings²,

terBrugge³

et al. 2009

AJNR Am J Neuroradiol

View full text Add to dashboard Cite

show abstract

“…STS is a widely used sclerosant agent which has been available in Canada and Europe for many years and is primarily used in the treatment of varicose veins. STS has been approved by the US Food and Drug Administration FDA for sclerotherapy of varicose veins [17,18]. In this case series, our clinical experience with the use of STS 3 % solution tends to validate STS as a minimally invasive, safe, and effective treatment of head and neck VnM.…”

Section: Discussionmentioning

confidence: 81%

The Use of Sodium Tetradecyl Sulphate for the Treatment of Venous Malformations of the Head and Neck

Alakailly

Kummoona

Quereshy

et al. 2014

J. Maxillofac. Oral Surg.

View full text Add to dashboard Cite

Introduction Vascular malformations have devastating cosmetic effects in addition to being associated with pain and bleeding. Sclerotherapy has been used as an effective therapeutic modality for the management of vascular malformations. The purpose of this case series is to describe our clinical experience of using sodium tetradecyl sulphate (STS) 3 % in the treatment of venous malformation lesions of head and neck. Materials and Methods Thirteen patients were included in this study (three male and ten female; age range between 8 months and 54 years; mean age 18.2 years, ±SD 15.71). The patients were treated by 3 % STS intralesional injections. Of the thirteen patients treated, complete resolution occurred in four patients (28.57 %), a good response occurred in five patients (35.7 %), a moderate response in two patients (14.28 %), a mild response in two patients (14.28 %) and no response in one patient (7.14 %). The side effects encountered in all patients were pain and edema after injection which was controlled by oral analgesics and an intramuscular injection of dexamethasone. In addition, two patients developed a superficial ulceration (11.76 %) which healed uneventfully, and one patient developed ecchymosis after injection (5.88 %). Conclusion Sclerotherapy with 3 % STS is a simple, safe, and effective modality for the treatment of venous malformations.

show abstract

“…While some authors evaluate overall patient satisfaction using a self-assessment questionnaire, others attempt to quantify morphologic response [29]. Given the possible discrepancy between the clinical and morphologic response, there are arguments for both methods [14,30]. As an argument for patients to undergo sclerotherapy, satisfaction based on self-assessment seems to be a useful instrument, since all studies show comparable satisfaction in up to 80 % of cases, as Nakamura et al could show in their cohort of 40 patients [31].…”

Section: Discussionmentioning

confidence: 99%

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

Clemens

Baumann

Husmann

et al. 2017

Vasa

View full text Add to dashboard Cite

Summary:Background: Congenital venous malformations are frequently treated with sclerotherapy. Primary treatment goal is to control the often size-related symptoms. Functional impairment and aesthetical aspects as well as satisfaction have rarely been evaluated. Patients and methods: Medical records of patients who underwent sclerotherapy of spongiform venous malformations were reviewed and included in this retrospective study. The outcome of sclerotherapy as self-reported by patients was assessed in a 21 item questionnaire. Results: Questionnaires were sent to 166 patients with a total of 327 procedures. Seventy-seven patients (48 %) with a total of 159 procedures (50 %) responded to the survey. Fifty-seven percent of patients were male. The age ranged from 1 to 38.1 years with a median age of 16.4 years. The lower extremities were the most common treated area. Limitations caused by the venous malformation improved in the majority of patients (e.g. pain improvement 87 %, improvement of swelling 83 %) but also worsening of symptoms occurred in a minority of cases. Seventy-seven per cent would undergo sclerotherapy again. Conclusions: Sclerotherapy for treatment of venous malformations results in signifi cant reduction of symptoms. Multiple treatments are often needed, but patients are willing to undergo them.

show abstract

Percutaneous Sodium Tetradecyl Sulfate Sclerotherapy for Peripheral Venous Vascular Malformations: A Single-Center Experience

Cited by 79 publications

References 24 publications

Percutaneous Sclerotherapy for Facial Venous Malformations: Subjective Clinical and Objective MR Imaging Follow-Up Results

Percutaneous Sclerotherapy for Facial Venous Malformations: Subjective Clinical and Objective MR Imaging Follow-Up Results

The Use of Sodium Tetradecyl Sulphate for the Treatment of Venous Malformations of the Head and Neck

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

Contact Info

Product

Resources

About